Publicerad: 2022-01-26 15:58 | Uppdaterad: 2022-01-28 08:35

Aktuella utlysningar, vecka 4, 2022

Grants Office tipsar om aktuella utlysningar

Svenska och nordiska anslag

 

Cecilia Falkman Memorial Foundation – Riksförbundet Cystisk Fibros, SE

This promotes scientific, clinical and social research as well as other activities related to cystic fibrosis.

Closing date: 1 February 2022 

Further information 

 

Grant for clinical studies within therapy research – Vetenskapsrådet

This aims to enable a constellation of researchers within regions and academia to work together on clinical therapy studies that are justified by the needs of health and medical care. Grants are worth between SEK 1-20 million for up to four years.

Closing date: 22 February 2022

Further information 

 

Childhood cancer research funding – Mary Béves Stiftelse för Barncancerforskning

These support research and development of childhood cancer care and the exchange of information between researchers. The total budget is SEK 900,000.

Closing date: 25 February 2022

Further information 

 

Proposals for Residencies & Workshops – The Brocher Foundation

The Brocher Foundation offers researchers the opportunity of a 1-3 months Residency or to organize a 2 or 3 days multidisciplinary Workshop on the Ethical, Legal and Social Implications of new medical developments.

Closing date: 25 February 2022

Further information 

 

Research and development grants in occupational environment and health – AFA Insurance

The call is aimed to prevent work related injuries and prolonged sick leave.

Closing date: 23 February 2022

Further information 

 

Travel grants for doctoral students in preclinical and clinical medical research – Swedish Society for Medical Research (SSMF)

These aim cover personal costs in connection with travel to another research institution or clinic for studies of significance to the applicant's own research project. Grants are worth up to SEK 50,000 and are granted a maximum of three times.

Closing date: 1 March 2022

Further information 

 

Funding for clinical researchers - Region Stockholm, Karolinska Institutet

Funding for senior clinical researchers

This supports clinically oriented medical research. Funding is worth up to SEK 400,000 each per year for up to four years.

Funding for postdoctoral clinical research

This supports postdoctoral clinical researchers. Support is available for ten researchers and is worth SEK 500,000 each per year for two years, with the possibility of extension for another two years.

Closing date: 16 March 2022

Further information 

 

Project grants within cancer research – The Sjöberg Foundation

The Sjöberg Foundation supports cancer research, by supporting research projects, and, also awarding an international scholarship, the "Sjöberg Prize".

In 2022 the research areas for the project grant call are: Preventive measures and care, including complementary and integrative medicine and measures against long-term complications, and, Early diagnosis and difficult-to-treat cancer with poor prognosis and also "drug repurposing".

In accordance with the donor's wishes, applications for unconventional medicines / treatment methods are of interest.

Closing dates: Pre-proposal 31 March 2022, Full grant application 10 September 2022.

Further information 

 

Research months for clinical projects – Swedish Cancer Society

These aim to enable cancer researchers with clinical service in medical, healthcare, social and behavioural science activities to set aside time for research. Funding is in the form of salary compensation worth SEK 140,700 for between one to three months, for a maximum of three years.

Closing date: 2 May 2022

Further information 

 

Life science, health, welfare technologies and clinical research – Innovation Fund Denmark

This supports Denmark’s strong knowledge and research position within the field to be transformed into inventions, products, and technologies, which benefit Denmark. Two tracks are available to apply for: life science, health and welfare technology with an overall budget of DKK 127,4m, awarding grants between DKK 5m and DKK 40m; and stem cell research center with an overall budget of DKK 24,5m awarding grants between DKK 5m and DKK 24,5m.

Any legal entity, such as an enterprise, a research institution or a public institution, in or outside Denmark, directly involved in the project activities, is eligible to apply. One of the Danish project participants must act as the applicant organisation. Grants are worth between DKK 5 million and DKK 40 million over one to five years.

Closing date: 5 April 2022

Further information 

 

Symposia grant – Marcus Wallenberg Foundation for International Scientific Cooperation

These support symposia held in Sweden of high scientific quality that have an international orientation and are attended by international participants. The maximum award: SEK 250,000

Closing date: 1 October 2022

Further information 

 

RSMH utlyser forskningsstipendium för 2022

Riksförbundet för Social och Mental Hälsa (RSMH) arbetar för att människor med psykisk ohälsa ska ges förutsättningar att komma tillbaka till ett gott liv. Varje år delar vi ut ett forskningsstipendium på 40 000 kronor ur vår stipendiefond.

Enligt fondens stadgar kan stipendium sökas av en person som bedriver humanistiskt och socialt inriktad forskning som kan leda till ett bättre liv för människor med psykisk ohälsa. Forskning som sätter brukarens erfarenhet och kunskap i fokus ska särskilt uppmärksammas.

Vi ser stipendiet som en ”igångsättningshjälp” till forskare och doktorander/blivande doktorander som ännu inte är etablerade och som presenterar en intressant idé. Medlen får dock inte användas till resor, översättning eller inköp av dator/programvara.

Om ansökan till stipendiet

Ansökan ska innehålla följande uppgifter:

•    Sökandens namn och personnummer, adress, telefonnummer och e-post.
•    Uppgift om akademisk examen, nuvarande sysselsättning (anställning eller motsvarande) och arbetsplats/institution.
•    Kort sammanfattning av forskningsplan med grundläggande idé samt tids- och ekonomisk plan där det framgår hur medel från stipendiet ska disponeras.
•    Forskningsplan, meritförteckning och gärna referenser

Ansökan ska skickas senast den 31 mars 2022 till sokforskningsstipendier@rsmh.se

Vid publicering av forskningsresultat med anslag från RSMH:s Stipendiefond ska förbundets namn anges. Redovisning av medlens användning och forskningsresultat ska inges senast 18 månader efter stipendiets utbetalning.

 

Inbjudan till Utlysningsåret 2022 Vetenskapsrådet

Tid: Måndagen den 31 januari, kl.9.00-12.00  

Plats: Digitalt möte  i Zoom. Länk skickas ut kort innan mötet.  

Anmälan: Senast 28 januari

Ytterligare information och anmälan!

 

Möjlighet att ansöka om forskningsbidrag från Hjärnfonden

Nu är det dags att ansöka om forskningsbidrag från Hjärnfonden.  2022 års ansökningsomgång är öppen från och med den 28 januari till och med den 1 mars 2022. Hjärnfonden stödjer kvalificerad forskning om hjärnan och övriga nervsystemet samt sjukdomar, skador och funktionsnedsättningar i hela nervsystemet.
Storleken på stödet är vanligtvis 600 000 kronor per år under ett, två eller tre år och riktar sig till projekt inom hela det neurovetenskapliga området. Högre belopp och längre bidragsperioder kan komma ifråga för projekt som av Hjärnfondens Vetenskapliga nämnd bedöms vara av särskild vikt och hög kvalitet.

Det går även att erhålla forskningsbidrag med särskilt stöd från Team Rynkeby-God Morgon Skolloppet. Forskningen ska vara inriktad mot psykisk ohälsa hos barn och unga.

Läs mer om ansökan här

Har du frågor angående ansökan, vänligen mejla: forskningsstod@hjarnfonden.se

Europeiska anslag

 

Postdoctoral fellowships - Jérôme Lejeune Foundation

The Jérôme Lejeune Foundation invites applications for its postdoctoral fellowships. These support the career development of promising young scientists working on fundamental, translational and clinical aspects of down syndrome. For this round, only projects focusing on Down syndrome and co-occurring disorders are eligible.

Applicants must hold a doctoral degree or equivalent and conduct their research at an academic institution. The fellowship is worth €130,000 for two years.

Closing date: 20 February 2022

Further information 

 

Anne Maurer-Cecchini award - Anne Maurer-Cecchini Foundation

The Anne Maurer-Cecchini Foundation invites applications for the Anne Maurer-Cecchini award. This supports clinical or epidemiological research performed in the field of neglected tropical diseases. The aim is to help the winner to continue their research. The award targets the following conditions: •Buruli ulcer; •leprosy; •noma – cancrum oris; •enteric fever; •trachoma; •endemic trepanomatosis; •intestinal and hepatic helminthiasis; •intestinal protozoal infections; •human African trypanosomiasis; •American trypanosomiasis; •leishmaniasis; •neurocysticercosis; •cystic echinococcosis; •schistosomiasis; •lymphatic filarisasis; •onchocerciasis; •dracunculiasis; •trichinellosis; •snake bites.

Investigators and research groups who have completed a clinical or epidemiological study in 2020 or 2021 on one of the neglected tropical diseases may apply.

The award is worth CHF 20,000. It may occasionally be shared between two research works.

Closing date: 25 February 2022

Further information 

 

Early-career grants - Human Frontier Science Program

The Human Frontier Science Programme invites applications for its early-career grants. These support teams of early-career researchers working on innovative approaches to understanding complex mechanisms of living organisms.

Teams comprising scientists who are all within five years of obtaining an independent position and who have received their PhD or equivalent qualification within the 10 years prior to the application deadline, may apply. Only one application per institution may be submitted.

Closing date (letter of intent-registration): 24 March 2022

Further information 

 

Programme grants - Human Frontier Science Program

The Human Frontier Science Programme invites applications for its programme grants. These support teams of researchers at any career stage working on innovative approaches to understand complex mechanisms of living organisms. The aim is to allow teams of independent researchers to develop new lines of research through collaboration and to answer questions that could not be answered in individual laboratories.

Teams of independent researchers at any career stage may apply. Teams must comprise between two and four members. The principal applicant must be located in one of the HFSP member countries but co-investigators may be located in any country. Only one application per institution may be submitted.

Closing date (letter of intent-registration): 24 March 2022

Further information

 

Disrupting drug resistance using innovative design – JPIAMR

In line with the JPIAMR Strategic Research and Innovation Agenda, this call will focus on tackling the rising threat of antimicrobial resistance. Declining effectiveness of existing antimicrobials together with the low and insufficient number of promising new antimicrobials in the pipeline stresses the urgency to develop new protocols and innovative approaches for effective delivery and use of the already existing antimicrobials. This call aims to improve the treatment of bacterial and fungal infections (including co-infection) and/or the prevention of the emergence/spread of resistance in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents.

Through this call, the ERA-NET JPIAMR-ACTION intends to create and reinforce the collaboration between research partners coming from different countries and different fields of expertise to promote research on antimicrobial resistance.

Closing dates (parallel applications are needed for Swedish participants):

Consortium application to JPIAMR: 8 March 2022

Swedish project leader’s application in Prisma: 15 March 2022

JPIAMR

The Swedish research council

Amerikanska anslag

 

Federal Funding agencies

 

BRAIN initiative – new technologies and novel approaches for large-scale recording and modulation in the nervous system (R01 clinical trial not allowed), NIH

A total of 10 participating institutes of the National Institutes of Health invite applications for their Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative – new technologies and novel approaches for large-scale recording and modulation in the nervous system (R01 clinical trial not allowed) funding opportunity.

Deadline: May 02, 2022; October 28, 2022; May 01, 2023; October 27, 2023. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-NS-21-026

Further information

 

Neural regulation of cancer (R21 clinical trial not allowed), NIH

This Funding Opportunity Announcement (FOA) encourages collaborative, transdisciplinary research with both neuroscience and cancer research elements, which together will advance our current understanding of the nervous system's contribution to cancer. Leveraging the knowledge, tools, experimental models and reagents in neuroscience research to uncover novel mechanisms used by the nervous system to promote tumor initiation, progression and metastasis can ultimately inform key areas of cancer research including the prevention and treatment of non-central nervous system tumors.

Deadline: May 27, 2022. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-19-354

Further information: PAR-19-354: Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) (nih.gov)

 

Foundations

 

Pilot award- Neuroendocrine Tumor Research Foundation, US

The Neuroendocrine Tumor Research Foundation invites letters of intent for its pilot award. This supports innovative and transformative research on neuroendocrine cancers. Proposals are expected to address one or two smaller aims.

Teams and individual investigators may apply. Projects may include only one PI with or without collaborators. Applicants must hold an MD, PhD or equivalent and have a faculty appointment as assistant professor or above at a public or private institution, such as a university, college, hospital or laboratory, anywhere in the world. Projects that bring together investigators from diverse scientific disciplines are highly encouraged. Prior research in this field is not a prerequisite. Expert scientists wishing to enter the field are encouraged to apply.

Two to three awards are available, worth USD 100,000 each over one year. In addition, up to USD 2,000 may be provided to offset costs to attend the foundation’s annual research symposium, if the event is held in person.

Deadline: Letters of Intent (LOI) due March 7, 2022.

Further information: Pilot Award - NETRF

 

Investigator award- Neuroendocrine Tumor Research Foundation, US

The Neuroendocrine Tumor Research Foundation invites letters of intent for its investigator awards. These support proposals with two aims, or three smaller aims, related to studying neuroendocrine cancers in innovative and transformative ways. Projects should have only one PI with or without collaborators. They can be considered equivalent to an NIH R21 grant. Projects that bring together investigators from diverse scientific disciplines are highly encouraged.

Applicants must hold an MD, PhD or equivalent degree and a faculty appointment at or above the level of assistant professor. They may be based at public or private institutions, including universities, colleges, hospitals and laboratories, anywhere in the world. Prior research in this field is not a prerequisite. Expert scientists wishing to enter the field are encouraged to apply.

Up to two grants are available, worth USD 300,000 each over two years. In addition, up to USD ,000 may be provided to offset costs to attend the foundation’s annual research symposium, if the event is held in person.

Deadline: Letters of Intent (LOI) due March 7, 2022.

Further information: Investigator Awards - NETRF

 

Accelerator awards- Neuroendocrine Tumor Research Foundation, US

The Neuroendocrine Tumor Research Foundation invites letters of intent for its accelerator awards. These support investigators and teams in studying neuroendocrine cancers in innovative and transformative ways. Projects will often be multi-disciplinary or multi-institutional. They can be considered equivalent to an NIH RO1 grant. Projects that bring together investigators from diverse scientific disciplines are highly encouraged.

Candidates with an MD, PhD or equivalent who have a faculty appointment as assistant professor or above at a public or private institution, such as a university, college, hospital or laboratory, anywhere in the world may apply. Prior research in this field is not a prerequisite. Expert scientists wishing to enter the field are encouraged to apply.

At least one award is available, worth USD 1.2 million over four years. In addition, up to USD 2,000 may be provided to offset costs to attend the foundation’s annual research symposium, if the event is held in person.

Deadline: Letters of Intent (LOI) due March 7, 2022.

Further information: NETRF Accelerator Grant

Publicerad: 2022-01-20 09:37 | Uppdaterad: 2022-01-21 12:07

Aktuella utlysningar, vecka 3, 2022

Grants Office tipsar om aktuella utlysningar

Svenska och nordiska anslag

 

Wenner-Gren Stiftelserna

Wenner-Gren Fellow-stipendier: syftar till att ge unga forskare möjlighet att erhålla kvalificerad postdoktoral utbildning utomlands under 3 år samt att därefter (efter förnyat ansökningsförfarande) bedriva forskningsverksamhet i Sverige under 2 år.

Closing date: 1 February 2022

Further information 

  • Gästforskarstipendier: avsedda att underlätta för utländska seniora forskare att verka i Sverige. Sökes av svensk forskare som är värd för utländsk forskare.
  • Sabbatsstipendier: avsedda att möjliggöra för svensk senior forskare, vanligen professor, att verka vid utländsk vetenskaplig institution.
  • Resestipendier: avsedda för kortare tids besök utomlands för aktivt deltagande i internationella kongresser, symposier, workshops och kurser. Medel ges inte för forskningsvistelser utomlands.
  • Symposier: anslagen är avsedda som bidrag till organiserandet av internationella symposier som hålls i Sverige.

Closing date: 10 Mar 2022

Further information 

 

Forskningsstipendier – Demensförbundet: Stiftelsen Demensfonden

Fonden delar ut stipendier en gång om året för medicinsk forskning, omvårdnadsforskning, utveckling av stöd till demenssjuka och deras anhöriga samt informations- och kunskapsspridning om demenssjukdomar och anhörigas situation.

Closing date: 10 February 2022

Further information 

 

ALF medicine project grants - Region Stockholm

Supports clinically oriented medical research and development projects. The total budget is SEK 81 million. Funding is worth between SEK 300,000 and SEK 1.1m per year for up to three years.

Closing date: 16 February 2022

Further information 

 

Swedish Society of Medicine

  • Regnell’s prize: rewards unpublished articles on topics belonging to the field of medical research. The prize is worth SEK 130,000.
     
  • Erna Ebelings prize: promotes research and development in medical physics and medical technology. The price is worth SEK 35,000.
     
  • Ingvar prize: awards contributions within the field of neuroscience. The prize is worth SEK 35,000.
     
  • Hamberger prize: awarded to outstanding scientific contributions from a younger researcher in otorhinolaryngology. The prize is worth SEK 25,000.
     
  • Sustainability prize: awarded to doctors who promote and work with the sustainability of the healthcare sector. The prize is worth SEK 25,000.

Closing date: 1 March 2022

Further information 

 

E-infrastructure collaboration developement projects - NordForsk

Aims to develop services for a wide range of research problems within e-infrastructure of joint Nordic interest. The total budget is NOK 21.3 million.

Closing date: 1 March 2022

Further information 

 

E-infrastructure collaboration on community-forming pre-studies or workshops NordForsk

Support pre-studies or workshops enabling Nordic teams-in-formation to explore synergies of common e-infrastructure solutions and the potential to scope a future development project of joint Nordic interest. The grant is worth up to NOK 200,000.

Closing date: 1 March 2022

Further information 

 

Research call: Disrupting drug Resistance Using Innovative Design – Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)

This call aims to improve the treatment of bacterial and fungal infections (including co-infection) and/or the prevention of the emergence/spread of resistance in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents.

Closing date: 8 March 2022

Further information 

 

Distinguished innovator grant - Novo Nordisk Foundation

Enables a researcher in the life sciences to explore the commercial potential of a discovery while remaining embedded in academia. Grants are worth up to DKK 6 million over three years.

Closing date: 9 March 2022

Further information 

 

Pioneer innovator grants - Novo Nordisk Foundation

Support application-oriented research within the life sciences and to stimulate the evaluation of ideas that may lead to the development of new medical treatment, disease prevention, diagnostic methods as well as new health technologies, devices and technological platforms benefiting people and the society. Grants are worth up to DKK 1 million each for 12 months.

Closing date: 9 March 2022

Further information 

 

Sigbrith Björkelunds Stiftelse - medel att söka för kvinnliga forskare på KI eller UU

Sigbrith Björkelunds Stiftelse delar ut bidrag till kvinnliga forskare vid  Karolinska Institutet eller Uppsala Universitet verksamma inom områdena neurologi, psykiatri eller hjärt-kärlsjukdomar.

Stiftelsens bidrag avser i första hand att finansiera kostnader i samband med vistelse vid forskningsinstitution utanför Sverige, bidrag som på annat sätt stödjer mottagarens forskningsarbete kan även komma i fråga. (Kommentar – det senare alternativet kan vara aktuellt då utlandsvistelser nu försvåras/omöjliggörs på grund av Covid19-pandemin).

Mottagare ska ha avlagt läkarexamen och antingen befinna sig i senare delen av utbildningen på forskarnivå eller ha avlagt doktorsexamen under de fem senaste åren.

För utdelning 2022 avser Stiftelsen att lämna ett eller flera bidrag om vardera högst 100 000 kronor. Ansökan ska vara Stiftelsen tillhanda senast måndag 31 januari 2022 för medel som primärt avses att nyttjas under perioden juli 2022 – juni 2023.

För ytterligare information och ansökan se stiftelsens hemsida

 

Svensk-Franska Stiftelsen utlyser medel

Svensk-Franska Stiftelsen har sedan 1935 verkat för att främja kontakterna mellan Sverige och Frankrike genom att dela ut stipendier för eftergymnasiala studier och forskningsutbyte i Frankrike. Stiftelsen har en uttalad ambition att öka antalet ansökningar för forskningsutbyte och välkomnar forskare att ansöka i kommande omgång. Stiftelsens inriktning är bred och forskare från olika vetenskapliga inriktningar välkomnas. Stiftelsens stadgar stipulerar att man måste vara svensk medborgare för att kunna tilldelas medel.  

Stiftelsen har de senaste åren delat ut ca 700-800 tkr per år. Det maximala beloppet per ansökan är 200 tkr.

Sista ansökningsdag är den 15:e april och sker via stiftelsens hemsida

Frågor kan sändas till anna.jakobson@svensk-franska-stiftelsen.se 
 

Sök medel för forskning om Östersjöregionen och Östeuropa

Östersjöstiftelsen utlyser medel för forskning om Östersjöregionen och Östeuropa. Såväl enskilda forskare som forskargrupper är välkomna att söka anslag från stiftelsen. Forskare från Sverige och andra länder kan ingå i ansökningar till stiftelsen och ansökningarna kan omfatta alla discipliner. Forskningsprojekt som beviljas medel ska förläggas till Södertörns högskola.

Forskarna identifierar själva sina forskningsproblem. Efter utlysningen bedöms ansökningarna av experter i stiftelsens bedömarpaneler och av externa, oftast internationellt, sakkunniga. Avgörande i bedömningen är ansökningarnas vetenskapliga kvalitet och anknytningen till Östersjöregionen och Östeuropa.

  • Forskarnätverk
  • Postdokprojekt
  • Två- och treåriga projekt
  • Storprojekt

Ansökningssystemet öppnar måndagen  den 10 januari 2022. Sista ansökningsdag för samtliga stödformer är onsdagen den 2 februari 2022. 

Mer information på Östersjöstiftelsen

Europeiska anslag

 

ERC-2022-AdG Advanced Grants — the call is now open!

European Research Council (ERC) Advanced Grants support established, leading principal investigators who want long-term funding to pursue a ground-breaking, high-risk project. Applicants should be exceptional leaders in terms of originality and significance of their research contributions, with a track record of significant research achievements in the last ten years.  Applications may be made in any field of research, with an emphasis on the frontiers of science, scholarship, and engineering.

ERC Advanced Grants may be awarded up to €2.5 million for a period of 5 years, though an additional €1 million can be made available under certain circumstances.

If you are interested in applying for an ERC Advanced Grant with KI as host institution, please contact KI Grants Office for information about required documents and application support.

Closing date: 28 April 2022

Advanced Grants ERC 

 

EFSD/Sanofi European diabetes research programme in diabetes associated with cardiovascular disease - European Association for the Study of Diabetes

The European Association for the Study of Diabetes and Sanofi invite applications for their European diabetes research programme in diabetes associated with cardiovascular disease. This supports European research aimed at improving understanding of cardiovascular disease associated with diabetes. Grants are offered for basic and clinical studies. Translational studies are especially welcome.

Single non-profit institutions or groups of such institutions from Europe and associated countries may apply. The PI and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work based in Europe or an associated country. Grants are worth up to €100,000 each for at least one year.

Closing Date: 15 March 2022

Futher information 

 

NEXT start-up grant - European Society of Intensive Care Medicine

The European Society of Intensive Care invites proposals for its NEXT start-up grant. This enables the professional development of newly board-certified intensive care physicians to develop their independent research programmes in the field of intensive care and emergency medicine. Research programme proposals may rely on approaches ranging from basic cellular responses to outcome research, and may include clinical applications as well as translational science.

Board-certified intensive care physicians within five years from consultancy who can demonstrate a solid background in research may apply. Applicants must demonstrate institutional support to facilitate research activities and professional development. They must be members of the society and aged 42 or younger. The projects must be conducted in Europe. The proposal has to include at least three different countries contributing to the design or conduct of the project. Funding is worth €25,000 per year for up to two years.

Closing Date: 22 March 2022

Further information 

 

EMBO Workshop Grants

The European Molecular Biology Organisation invites applications for its grants to support workshops. These enable the organisation of workshops that cover different and evolving aspects of life-science related subject areas, and bring scientists together to present their findings.

Workshops must take place in an EMBC members state, an EMBC associate member state or cooperating partner countries. In rare cases, EMBO may consider applications for workshops taking place in other regions of the world. Workshops should last between two and a half and five days and attract between 80 and 450 participants. Organisers may be of any nationality and can be based in any country. Up to €39,000 is available per workshop.

Closing Date: 1 March 2022

Further information

 

Research grants - Cure Parkinson’s Trust

The Cure Parkinson’s Trust invites applications for its research grants. These support laboratory or clinical research projects that have the potential to advance knowledge that might lead to a cure for Parkinson’s disease. Applications must be for research that slows, stops or reverses underlying disease progression. Priority is given to research which has potential to translate into the clinic within five years. Applications are invited world wide. Grants are worth up to £250,000 each.

Closing Date: 11 March 2022

Further information 

Amerikanska och övriga internationella anslag
 

Federal Funding agencies

 

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed), NIH

This Funding Opportunity Announcement (FOA) invites grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research. This FOA solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer. Projects proposing the application of existing technologies where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.

Deadline: April 22, 2022; September 22, 2022. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-CA-22-002

Further info: RFA-CA-22-002: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (nih.gov)

 

Discovery of biomarkers and biomarker signatures for neurological and neuromuscular disorders (R61/R33 clinical trial optional): AIDS-related, NIH

The overarching purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and/or early evaluation of strong candidate biomarkers and biomarker signatures that can be used as tools to facilitate the clinical development of neurotherapeutics and their use in clinical practice. Specifically, the focus of this FOA is on the identification and initial biological, analytical and clinical evaluation of biomarkers and biomarker signatures for neurological and neuromuscular disorders/diseases. Although research supported by this FOA can include animal studies, it must also include preliminary human evaluation using carefully standardized human samples or datasets. The goal of this initiative is to deliver candidate biomarkers or biomarker signatures that are ready for definitive analytical and clinical validation studies.

Deadline: All types of non-AIDS applications allowed for this funding opportunity announcement are due on February 22, 2022 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on May 7, 2022 by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-19-315

Further info: PAR-19-315: Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) (nih.gov)

 

Technology development for single-molecule protein sequencing and single-cell proteome analysis (R01, R21 clinical trial not allowed), NIH

This Funding Opportunity Announcement (FOA) solicits grant applications to catalyze major advances in single-molecule protein sequencing and single cell proteome analysis through technology development. The goal of this initiative is to achieve technological advances over the next five years that enable generation of protein sequencing data at sufficient scale, speed, cost and accuracy to use routinely in studies of genome biology and function, and in biomedical and clinical research in general.

This funding opportunity uses the NIH research project (R01) grant mechanism and runs in parallel with one of identical scientific scope, RFA-HG-21-002, which solicits applications under the NIH exploratory/developmental (R21) grant mechanism.

Deadline: June 15, 2022; June 15, 2023.  Letter of Intent Due Date: 30 days prior to the application due date. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA):  RFA-HG-21-001 (R01), RFA-HG-21-002 (R21).

Further info: RFA-HG-21-001: Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) (nih.gov) (R01), RFA-HG-21-002: Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed) (nih.gov) (R21)

 

Foundations
 

Litwin inflammatory bowel diseases pioneers initiative - Crohn’s and Colitis Foundation of America, US

Crohn’s and Colitis Foundation of America invites letters of intent for the Litwin inflammatory bowel diseases (IBD) pioneers initiative. This supports innovative clinical and translational research projects with the potential to impact the treatment of IBD patients in the near future. Novel research into the diagnosis, identification of clinically relevant subsets, treatments, and cures for IBD. The aim is to fund innovative pilot research so that scientists can test their initial ideas and generate preliminary data.The PI must have a faculty appointment at the institution, and there can be only one PI for each proposal.

There is no fixed upper or lower limit of funding, but awards are generally worth up to USD 130,000, including 10% indirect costs. Funding can be requested for up to two years, but grants are funded only one year at a time.

 

Deadline: Letter of Intent: May 5th, 2022, 11:59pm EST. Online Application Submission: July 20th, 2022, 11:59pm EST.

Further info: Litwin IBD Pioneers | Crohn's & Colitis Foundation (crohnscolitisfoundation.org)


Sök stipendier och anslag för forskning, studier, examensarbete eller praktik i Japan!

Scandinavia-Japan Sasakawa Foundation (SJSF). Den svenska sektionen av stiftelsen utlyser anslag och stipendier för forskning och studier i Japan. 

•    Ämnen: forskning eller utbildning inom naturvetenskap, teknik, medicin, samhällsvetenskap, ekonomi, humaniora (inkl. japanska) och journalistik.
•    Behöriga att söka: organisationer, institutioner och enskilda personer. Sökande skall ha fast anknytning till Sverige.
•    Vistelse i Japan: från 1 vecka till 1 år, under perioden april 2022 –mars 2023.

Deadline 1 mars 2022. 

Scandinavia-Japan Sasakawa Foundation (SJSF) 
 

Sweden-Japan Foundation (SJF). Stiftelsen utlyser stipendier för studier, forskning samt examensarbete och praktik på högskolenivå i Japan.  

•    Ämnen: studier inom teknik, naturvetenskap, ekonomi, juridik, medicin och handel.
•    Behöriga att söka: studenter och yngre forskare från universitet och högskolor i Sverige. Sökande skall ha fast anknytning till Sverige.
•    Vistelse i Japan: från 3 månader till 1 år, under perioden april 2022 –mars 2023.

Deadline 1 mars 2022. 

Sweden-Japan Foundation (SJF) 

Frågor som inte besvaras av hemsidorna? Kontakta Marie Tsujita Stephenson, info@swedenjapan.se 

Event type
Föreläsningar och seminarier
KIB Workshop: How to verify your publications in the Bibliometric Verification Toolkit

2022-05-03 13:00 - 14:30 Add to iCal
Online
Location
Zoom
Lead

I den här workshopen kommer vi att guida dig igenom hur du hittar och verifierar dina publikationer i KI:s bibliometrisystem. Vi kommer också ta dig igenom stegen för att sätta publiceringsadress på dina publikationer.

Denna workshop ges på engelska, men vi pratar också svenska.

Content

Kontakt

Event type
Föreläsningar och seminarier
KIB Workshop: Screening in Rayyan

2022-04-05 10:00 - 12:00 Add to iCal
Online
Location
Zoom
Lead

Att screena referenser för inkludering/exkludering är en viktig men ibland svår uppgift när man skriver en översikt. Denna workshop hjälper dig att komma igång med det gratis onlineverktyget Rayyan. Vi går igenom hur du skapar ett konto, olika sätt att samarbeta med andra granskare, möjligheter till blindning och mycket mer.

För att göra workshopen så effektiv som möjligt ser vi gärna att du har skapat ett konto i Rayyan före vi startar.

Content

Kontakt

Event type
Föreläsningar och seminarier
KIB Workshop: Screening in Rayyan

2022-03-23 10:00 - 12:00 Add to iCal
Online
Location
Zoom
Lead

Att screena referenser för inkludering/exkludering är en viktig men ibland svår uppgift när man skriver en översikt. Denna workshop hjälper dig att komma igång med det gratis onlineverktyget Rayyan. Vi går igenom hur du skapar ett konto, olika sätt att samarbeta med andra granskare, möjligheter till blindning och mycket mer.

För att göra workshopen så effektiv som möjligt ser vi gärna att du har skapat ett konto i Rayyan före vi startar.

Content

Kontakt

Event type
Föreläsningar och seminarier
KIB Presentation: Explore a protein across species with the Alliance of Genome Resources

2022-01-26 12:00 - 12:30 Add to iCal
Online
Location
Zoom
Lead

På 30 minuter kommer databasen Alliance of Genome Resources att presenteras. Databasen rekommenderas av Journal of Nucleic Acid Research (NAR), i deras databas-edition 2020. Med denna databas kan du göra molekylära jämförelser mellan olika försöksdjursmodeller.
För doktorander och forskare inom klinisk forskning eller translationell forskning. Presentationen är på engelska men vi pratar även svenska.

Content

Kontakt

Event type
Föreläsningar och seminarier
KIB Workshop: Writing the popular science summary of your thesis

2022-01-24 10:00 - 12:00 Add to iCal
Online
Location
Zoom
Lead

Förmågan att skriva om din forskning på ett sätt som är förståeligt och intressant för allmänheten är en viktig färdighet för alla forskare. Denna workshop ger dig verktyg för och praktisk övning i att anpassa innehåll, struktur och stil när du skriver den populärvetenskapliga sammanfattningen till din doktorsavhandling.
Workshopen riktar sig till doktorander som skriver ramberättelse till sin avhandling.
Workshoppen är på engelska men vi pratar även svenska.

Content

Kontakt

Event type
Annan
Karriärcoachning för doktorander, postdoktorer och forskare - begränsat erbjudande jan-feb 2022

2022-02-10 Add to iCal
Annan
Location
Newstart Stockholm office eller Online
Lead

Närmar du dig slutet på din tid på KI? Behöver du tänka om din karriär eller arbeta med personlig utveckling, och behöver lite personlig vägledning? Låt oss hjälpa dig!

Content

Mer info på engelsa sidan.

Publicerad: 2021-12-15 11:01 | Uppdaterad: 2021-12-15 11:27

Aktuella utlysningar, vecka 50, 2021

Grants Office tipsar om aktuella utlysningar.

Svenska och nordiska utlysningar

Student Degree Project Grant Programme –  SRP Diabetes

SRP Diabetes supports principal investigators planning to supervise a student in an educational program at KI (e.g. medical students, biomedicine program, master programmes) while the student performs his/her degree project work. Projects should be in the area of diabetes and/or metabolism.

Closing date:16 January 2022

Further information

Working environment project grants – Nordic Council of Ministers

These support research projects that promote a common Nordic experience and knowledge base for further development and modernisation of the working environment policy and administration in the Nordic countries. The total budget is worth DKK 2 million.

Closing date:1 February 2022

Further information

Post doc grants – Swedish Research Council for Health, Working Life and Welfare (Forte)

Forte’s annual call for postdoc grants aims to support competence and career development for junior researchers and to promote research mobility. The call is open to applications within Forte’s overall areas of responsibility: health, working life and welfare. The purpose of the call is to enable analysis of and contribute to an in-depth knowledge within defined research areas or issues. In total, around SEK 50 million is reserved for the period 2023-2024. Three types of grants are available within this call:

  • National postdoc grant - National postdoc grants are intended for researchers in Sweden who want to carry out their postdoc in Sweden.
  • International postdoc, Incoming - Incoming postdoc grants are intended for researchers abroad who wants to spend their postdoc period in Sweden.
  • International postdoc, Outgoing - Outgoing postdoc grants are meant for researchers in Sweden who wish to spend their postdoc period abroad.

Closing date: 24 February 2022

Further information

Europeiska utlysningar

EXTENDED DEADLINE: ESPID/INOPSU infection surveillance research grant - European Society for Paediatric Infectious Diseases

*** The closing date for this opportunity has been extended. The previous deadline of 1 March has been extended to 31 December 2021. All other call details remain unchanged. ***

The European Society for Paediatric Infectious Diseases and the International Network of Paediatric Surveillance Units invites applications for their infection surveillance research grant. This supports infection surveillance across two or more European countries and aims to facilitate infection surveillance research in Europe.

Applicants should be ESPID members in good standing. Applicants who have not previously received substantial research funding will be favoured. Projects must be directly relevant to paediatric infectious diseases. Applications should come from areas of Europe where there is currently little or no such work going on.

The grant covers administrative costs of the surveillance units, and a small amount of essential consumables of up to €20,000.

Closing date:  31 December 2021

Further information

Congenital adrenal hyperplasia grant - European Society for Paediatric Endocrinology

The European Society for Paediatric Endocrinology and the International Fund raising for Congenital Adrenal Hyperplasia invite letters of intent for their congenital adrenal hyperplasia grant. This supports research on congenital adrenal hyperplasia. Specific goals include:

•increasing knowledge on pathophysiology of the disease;

•prevention, diagnostic and treatment of natural or iatrogenic complications;

•proposition of new therapeutic targets and protocols.

Applicants must hold an MD, PhD or equivalent academic degree, and have a faculty position or equivalent at a college, university, medical school or comparable institution. Only one project per research team will be considered. Participation is open worldwide and should, if possible, include teams based in Europe.

The total budget is €350,000. Grants are worth up to €150,000 each over three years to cover expenses directly linked to the project, including specific equipment, operating costs or salaries of co-workers.

Closing date:15 January 2022 (Forecast)

Further information

COVID-19 response open call - Digital Innovation Hub Healthcare Robotics

The Digital Innovation Hub Healthcare Robotics invites proposals for its COVID-19 response open call. This accelerates the embedding of robotic applications in healthcare-related settings and enables the smooth deployment of new, effective robotic-based solutions. Proposals must clearly state the relevant clinical demand and the healthcare problem related to COVID-19 to be solved by the robotic application, as well as the added clinical value of the solution. It must be an already existing robotic system that is at technology readiness levels 7 to 8.

Consortia must include at least one SME or slightly larger company and four end-users from four different EU member states, associated countries or European Economic Area countries.

Eight grants worth up to €250,000 each over nine months are available.

Closing date:15 January 2022

Further information

Call for research proposals on radiofrequencies and health - French Agency for Food, Environmental and Occupational Health and Safety |

The French Agency for Food, Environmental and Occupational Health and Safety, under its national research programme for environmental and occupational health, invites letters of intent for its call for research proposals on radiofrequencies and health. This supports research projects that aim to evaluate or analyse the health risks associated with radiofrequencies, in the context of the general population and the workplace. The priority research themes are:

•mechanisms of action at the cellular level;

•physiological and health effects of radiofrequencies;

•hypersensitivity to electromagnetism;

•types of exposure.

Research teams belonging to any institution may apply. Non-research-oriented partners are permitted as long as their added value in the project has clearly been established. Proposals submitted by a French team may include a partnership with one or more foreign teams. Proposals submitted by a foreign team or a team that belongs to an international organisation must include a French academic partner.

Two types of proposal are eligible:

•feasibility studies, worth up to €50,000 over two years;

•complete projects, worth between €40,000 and €300,000 over two to three years.

Closing date:18 January 2022

Further information

Research grants - European Society of Cardiology

The European Society of Cardiology invites applications for its research grants. These enable members to undertake specialised cardiovascular research or further training in the field in an ESC regular member country. The goal is to help young candidates obtain research experience in a high standard academic centre, enabling them to contribute to the improvement of academic standards. Preference is given to applicants in countries or regions where modern clinical cardiology is not yet strong, provided that the applicant can contribute to the improvement of clinical cardiology upon their return.

Applicants must be below 40 years of age and be citizens or permanent residents of an ESC member or affiliated member country throughout the three years preceding the application date. Periods of residence dedicated to full-time education are not accepted as ordinary residence. They must hold a PhD or DPhil degree or equivalent, or must have submitted a thesis before taking up the fellowship. Medical graduates may apply if they have completed their basic professional training and are able to demonstrate their expertise through abstract presentation at a national or international meeting, or have published a paper in a relevant journal. Applicants must be members of the ESC. Applicants are allowed to apply to an institution based in their own country, provided it is not their home institution.

Grants are worth €25,000 each per year for projects lasting between three months and one year.

Closing date: 31 January 2022

Further information

EFSD/Lilly young investigator research awards - European Association for the Study of Diabetes

The European Foundation for the Study of Diabetes and Lilly invite applications for their young investigator research awards. These encourage innovative research in the field of diabetes and its complications, and promote excellence in medical education.

Applicants must be paid-up members of EASD and must have received their highest degree no more than five years ago for basic scientists, or seven years ago for clinicians on 1 January 2022. For clinicians holding more than one qualifying degree or with a clinical specialist degree, the time since the first degree must be no more than 10 years before January 1 2022. Research awards must be held at a non-profit institution based in Europe or an associated country.

Awards are worth €50,000 each.

Closing date:15 February 2022

Further information

Amerikanska utlysningar

Federal Funding agencies

Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional): NIH

The purpose of this Notice is to inform the community that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to publish a Funding Opportunity Announcement (FOA) that will invite broad investigator-initiated research projects proposing novel basic, translational, and clinical studies and efforts to develop new approaches to assess and treat pain for disorders within the NIDDK mission areas.

This upcoming FOA is expected to be published in the Winter of 2022 with an expected application due date in the Spring 2022. It will utilize the Research Project Grant (R01 Clinical Trial Optional) mechanism.

This Notice is provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This will be an open competition.

Further information 

Notice of Special Interest (NOSI): Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College: NIH

The purpose of this future grant application solicitation is to balance the NIAAA research portfolio by supporting research on alcohol misuse among persons aged 18 to 29 who are not enrolled in four-year colleges or universities. These persons are commonly in the military, workforce, or community college populations, which are understudied relative to their age peers in four-year colleges. Research on epidemiology, prevention, and screening centered on these understudied populations are all encouraged.

Further information 

Notice of Special Interest (NOSI): Methods Development for Genomic Studies of Genetic Variation, Function, and Disease: NIH

The National Human Genome Research Institute (NHGRI) is issuing this Notice of Special Interest (NOSI) to encourage applications that develop novel computational or experimental approaches for genomic studies of how genetic variants relate to genomic function, phenotype, and disease.

Further information 

Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial not Allowed): NIH

This Funding Opportunity Announcement (FOA) solicits R21 grant applications to innovate and develop the early stages of novel technologies that will enable greater than a one order of magnitude improvement in 1) DNA sequencing, and 2) methods for direct sequencing of the diversity of entire RNA molecules. Advances in genomics and more broadly in biomedical research have been greatly facilitated by cycles of technology innovation and disruption that have driven significant and sustained nucleic acid sequencing throughput and assembly quality increases combined with cost decreases and read quality improvements. The goal now is to dramatically advance DNA sequencing and direct RNA sequencing technologies at reasonable costs with the anticipation that significant exploratory innovation in any of these and related areas would make significant contributions to the mission of NHGRI and the field of genomics, including to many of NHGRI’s other technology development goals.

Closing date: March 1, 2022; February 1, 2023.

Funding Opportunity Announcement (FOA): RFA-HG-21-007

Further information 

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional): NIH

This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science.

Closing date: March 07, 2022, November 08, 2022, March 07, 2023, November 05, 2023, March 07, 2024.

Funding Opportunity Announcement (FOA): PAR-21-190

Further information 

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional): NIH

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.

Closing date: March 8, 2022, August 10, 2022, March 8, 2023, August 10, 2023, March 8, 2024.

Funding Opportunity Announcement (FOA): PAR-21-208

Further information 

Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed): NIH

This Funding Opportunity Announcement (FOA) supports mechanistic and early translational research focused on a more rigorous in-depth examination of the potential interactions of environmental toxins with genetic and non-genetic molecular targets known to influence Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD). It is expected that these studies will address the clinical relevance of these exposures on disease initiation, progression, or modification. Anticipated outcomes include an improved understanding of neurological mechanisms of chemical toxicities related to AD/ADRD, more evidence-based potential biomarkers of exposure and toxicity for those most at risk, as well as more data to support causality and potential approaches for mitigation. The scope of research includes mechanistic studies on the modification of known AD/ADRD targets by neurotoxins of concern, and conversely, whether known targets for these neurotoxins play a role in etiologies of AD/ADRD. The development and validation of neuropathological, neurophysiological and neurobehavioral animal models that simulate potential toxin exposures in humans is another example of supported studies. Preclinical studies of interactions of environmental toxicant with AD/ADRD in pilot human subject studies (that do not meet the NIH definition of clinical trial) are appropriate for this FOA. Interdisciplinary collaboration is required to address the various fields of study related to this research, e.g., neuroscience, aging, and environmental health sciences.

Closing date: March 11, 2022

Funding Opportunity Announcement (FOA): PAR-22-048

Further information 

 

Foundations

Walter Katkovsky research grants - American Psychological Association, US

The American Psychological Association invites applications for the Walter Katkovsky research grants. These support research on the general topic of psychotherapy. Research proposals should be directed to questions and hypotheses designed to improve understanding based on theory or methods of how psychotherapy promotes behavioural, emotional, or cognitive changes.

Applicants must have up to 12 years of postdoctoral experience and be affiliated with a non-profit charitable, educational or scientific institution, or government entity operating exclusively for charitable and educational purposes.

Grants are worth up to USD 20,000 each.

Closing date: March 1, 2022.

Further information 

Standard Research Grant - Scoliosis Research Society, US

The Scoliosis Research Society invites applications for its standard research grant. This supports research in the area of spinal deformities.

Applicants do not need to be members of the SRS but do need to have at least one SRS member as co-investigator. Research for independent manufacturers, industry development or personal business financial gain will not be supported.

The grant is worth up to USD 37,500 per year for a maximum period of two years.

Closing date:  Letters of Intent Collected*: February 1 - March 15 (11:59pm EST)
*Applicable to: Biedermann Innovation Award, New Investigator Grant, SRS-Cotrel Foundation Basic Science Grant, and Standard Research Grants
Application for Resident/Fellow Grants and Exploratory Micro-Grants Collected: February 1 - March 15 (11:59pm EST)
Requests for Full Proposals: No later than April 15
Full Proposal Applications Open: April 15 - May 15
Award Notifications: August

Further information 

Publicerad: 2021-12-09 10:33 | Uppdaterad: 2021-12-09 11:13

Aktuella utlysningar, vecka 49, 2021

Grants Office tipsar om aktuella anslag

Svenska och nordiska anslag

 

Erik Allardt fellowship - Helsinki Collegium for Advanced Studies

Enables one or two scholars, within social and human sciences, with an affiliation with a university in Sweden to undertake a fellowship at the collegium in Helsinki. Fellowship includes a monthly grant of €3,600 and a travel allowance of €1,000 per semester for either the entire academic year or one semester.

Closing date: 10 January 2022

Further information 

 

Call for projects – SRP Diabetes Postdoc Fellowships 2022

SRP Diabetes at KI started a new initiative earlier this year – the SRP Diabetes Postdoctoral Fellowship Programme. With this postdoctoral program SRP Diabetes aims to support the next generation of exceptional young scientists within the diabetes area, including both experimental and clinical research. This call is the first step in our second round of recruitment of 5 postdoctoral fellows for an expected start date in the autumn of 2022. Principal investigators at Karolinska Institutet are hereby invited to submit a project for consideration to the SRP Diabetes Postdoctoral Fellowship Program within basic, translational, clinical, and/or epidemiological research with an emphasis on diabetes and its comorbidities (e.g. cardiovascular and liver disease). Projects should have clear relevance for diabetic disease and principal investigators should document their track record in diabetes related research. Applications will be externally evaluated.

Closing date: 16 January 2022

Further information 
 

Doktorandmånader – Radiumhemmets forskningsfonder

Utlysningens syfte är att möjliggöra för kliniskt verksamma doktorander inom cancerområdet att genomföra sina doktorandprojekt genom att finansiera forskningstid. Medlen utlyses som lönemedel och kan sökas från och med registrering som doktorand till disputation.

Closing date: 30 January 2022

Further information 

 

Project grants - Swedish Research Council for Health, Working Life and Welfare (Forte)

The annual call for project grants is open to applications within Forte’s overall areas of responsibility: health, working life and welfare. Grants are worth up to SEK 3 million for two-year projects and up to SEK 5million for three-year projects.

Closing date: 3 February 2022

Further information 

 

EASD/Novo Nordisk Foundation diabetes prize for excellence

Recognises a body of research that has led to significant advances in the understanding, prevention or treatment of diabetes or its complications. The prize is worth DKK 6 million.

Closing date: 15 February 2022

Further information 

 

Lise Meitner Grants for Israeli-Swedish research collaboration – Swedish Foundation for Strategic Research (SSF)

In a collaboration between SSF and the Israeli Ministry of Innovation, Science and Technology, MOST, it is now possible to apply for grants in the joint program “Lise Meitner Grants for Israeli-Swedish research collaboration”. An amount of 50 million SEK is invested in applied research projects involving groups in Israel and Sweden of the highest international scientific standard. The aim is to enhance the two countries’ strong position in research and innovation and to create networks, which also can spread positive effects to other actors in academia and industry. Around eight projects will be supported by research grants, which should be used for joint research, seminars, conferences, workshops and exchanges of individuals between the applying groups over a period of five years.

Closing date: 21 February 2022

Further information 

Europeiska anslag

 

CERV-2022-EQUAL – call for proposals to promote equality and to fight against racism, xenophobia and discrimination - Directorate-General for Justice and Consumers

The Directorate-General for Justice and Consumers, under the citizens, equality, rights and values programme, invites proposals for its call to promote equality and to fight against racism, xenophobia and discrimination. This supports initiatives to prevent and fight against intolerance, racism, xenophobia, and discrimination, in particular on grounds of racial or ethnic origin, colour, religion, sexual orientation or gender identity. Proposals may specifically address the impact of the COVID-19 pandemic on these groups. Projects must fall within one of the following focus areas:

•fighting against intolerance, racism, xenophobia, discrimination, hate speech and hate crimes;

•promoting diversity management and inclusion at the workplace, both in the public and private sector;

•fighting discrimination against LGBTIQ people and promoting LGBTI equality through the implementation of the LGBTIQ equality strategy;

•preventing, reporting and countering hate speech online;

•improving public authority responses to discrimination, racism and xenophobia.

90 % coverage of direct costs and 7 % flat rate for indirect costs

Closing date: 24 February 2022

Further information 

 

EFSD/Novo Nordisk Foundation future leaders award programme - European Association for the Study of Diabetes

The European Foundation for the Study of Diabetes and the Novo Nordisk Foundation invite applications for their future leaders award programme. This supports clinical and basic scientists in transitioning from postdoctoral clinical fellow to a tenured faculty position in European diabetes research.

Closing date: 1 March 2022

Further information

 

EFSD/Sanofi outlook to the next 100 years of insulin – innovative insulin delivery and monitoring systems -

European Association for the Study of Diabetes

The European Foundation for the Study of Diabetes and Sanofi invites applications for their outlook to the next 100 years of insulin – innovative insulin delivery and monitoring systems programme. This supports basic and clinical-experimental studies understanding and improving insulin delivery and action.

Non-profit institutions or groups of such institutions from Europe and associated countries are eligible to apply. The PI and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work.

Grants are worth up to €100,000 each for one year or longer.

Closing date: 1 March 2022

Further information 

 

CERV-2022-GE — Call for proposals to promote gender equality - Directorate-General for Justice and Consumers

The Directore-General for Justic and Consumers, under its Citizens, Equality, Rights and Values Programme, invites proposals for its call to promote gender equality. This supports the advancement and implementation of policies to promote women’s full enjoyment of rights, freedom from gender stereotypes, gender equality, including work-life balance, women’s empowerment and gender mainstreaming. Projects may fall under the following areas:

•equal participation and representation of women and men in political and economic decision making;

•tackling gender stereotypes, including with a focus on youth, and in advertising and the media.

90 % coverage of direct costs and 7 % flat rate for indirect costs

Closing date: 16 March 2022

Further information 

 

Support to EFSA in the Safety Assessment of Novel Foods and Nutrient Sources – European Food Safety Authority

ref. GP/EFSA/NUTRI/2021/01

The overall objective of this call is the identification of several partners, among Art. 36 List competent organisations, to which EFSA can entrust at any time during the next 4 years the tasks of contributing to the preparatory work for the safety assessment of novel foods and nutrient sources performed by EFSA. The interested applicants shall cover at least one of the specified 7 areas:

  1. Product characterization
  2. Intake assessment
  3. Absorption, Distribution, Metabolism and Excretion (ADME) & Bioavailability
  4. Nutritional assessment
  5. Toxicological information
  6. Human studies
  7. Allergenicity

This grant is financed based on achievements of results (deliverables) under entrusted task within timeline.

Closing date: 17 February 2022

Further information 

Amerikanska anslag

 

Federal Funding agencies

 

Notice of Special Interest (NOSI): The Functional Oral Microbiome: NIH

The National Institute of Dental and Craniofacial Research (NIDCR) is issuing this Notice of Special Interest (NOSI) to encourage research studies that focus beyond the bacteria to the multispecies communities making up the oral microbiome.

To date, most microbiome studies focus on the bacteriome, despite the fact the term "microbiome" refers to all microorganisms. The oral microbiome is comprised of a multitude of organisms, including bacteria, fungi, viruses, archaea and protozoa, which serve an essential role in oral and systemic health. Despite a wealth of knowledge regarding specific species present, much remains unclear regarding the mechanisms driving the stability, persistence, and resistance of the oral community as a whole. Research studies responding to this NOSI must focus on exploring interkingdom microbial interactions or complex community systems and networks in physiologically relevant environments to understand the role of community interactions in the maintenance of health and in driving transition to dysbiosis and disease in the oral cavity. Outcomes from this NOSI are expected to be multi-dimensional and nuanced research that strengthens our understanding of the interconnectedness and uniqueness of the oral microbiome community.

This notice applies to due dates on or after February 5, 2022 and subsequent receipt dates through September 7, 2025.

Further information 

 

Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity: NIH

The purpose of this Notice of Special Interest (NOSI) is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. Understanding the genetic basis of primary immunodeficiency disorders is essential for their diagnosis, prognosis, and the development of precision therapeutics.

This notice applies to due dates on or after February 5, 2022, and subsequent receipt dates through January 7, 2025.

Further information 

 

Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology: NIH

The purpose of this Notice of Special Interest (NOSI) is to stimulate research on the role of RNA modifications in the area of cancer biology. Despite the recognition that RNA modifications and editing exert substantial impact on gene expression and function, there are a lack of mechanistic insights into the dynamic regulation of RNA modifications and how their de-regulation drives cancer formation. A better understanding of the extent, diversity and crosstalk between different types of RNA modification, and the elucidation of the molecular players that read and interpret the modification code are needed to reveal the mechanisms of RNA modifications that underly cancer formation and the cancer phenotype.

The first available date will be February 16, 2022 to April 22, 2022 pending on various funding opportunity announcements.

Further information 

 

Drug Discovery For Nervous System Disorders (R01, R21 Clinical Trials Not Allowed): NIH

This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA, NIMH, NIAAA, NIDA and NIA wish to stimulate research in: 1) Identification, design, synthesis, and preclinical testing of small molecules for their potential as candidate therapeutics ; 2) Initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) Later stage lead optimization to improve efficacy and pharmacokinetics; and 4) Initial drug metabolism and pharmacokinetic properties (DMPK). Emphasis will be placed on projects that provide novel approaches for identifying potential therapeutic agents.

R21 will also support applications proposing preclinical discovery of biotechnology products and biologics with potential as candidate therapeutics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies).

Deadline: NIH standard due dates.

Funding Opportunity Announcement (FOA): PAR-22-031 (R01); PAR-22-032 (R21).

Further information: (R01); (R21).

 

Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed): NIH

As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First), the NIH invites applications to submit samples from pediatric cohorts for whole genome sequencing at a Kids First-supported sequencing center. Applicants are encouraged to propose sequencing of existing pediatric cancer cohorts to elucidate the genetic contribution (somatic and/or germline) to childhood cancers, or to expand the range of disorders included within the Kids First Data Resource to investigate the genetic etiology of structural birth defects. The program will accept applications that propose whole genome, exome, and transcriptome sequencing, as well as epigenomic assays of tumor or affected tissue, when justified. These data, and associated clinical and phenotypic data, will become part of the Gabriella Miller Kids First Pediatric Data Resource (Kids First Data Resource) for the pediatric research community.

Deadline: February 23, 2022

Funding Opportunity Announcement (FOA): PAR-22-054

Further information 

 

Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial not Allowed): NIH

This Funding Opportunity Announcement (FOA) solicits R21 grant applications to innovate and develop the early stages of novel technologies that will enable greater than a one order of magnitude improvement in 1) DNA sequencing, and 2) methods for direct sequencing of the diversity of entire RNA molecules. Advances in genomics and more broadly in biomedical research have been greatly facilitated by cycles of technology innovation and disruption that have driven significant and sustained nucleic acid sequencing throughput and assembly quality increases combined with cost decreases and read quality improvements. The goal now is to dramatically advance DNA sequencing and direct RNA sequencing technologies at reasonable costs with the anticipation that significant exploratory innovation in any of these and related areas would make significant contributions to the mission of NHGRI and the field of genomics, including to many of NHGRI’s other technology development goals.

Deadline: March 1, 2022; February 1, 2023.

Funding Opportunity Announcement (FOA): RFA-HG-21-007

Further information

 

Foundations

 

Robert B Winter global outreach fellowship- Scoliosis Research Society, US

This 4-6 week spine fellowship is for highly-motivated spine surgeons who are currently in clinical practice in any financially-challenged under-served area worldwide, and who are in a position which will enable them to disseminate knowledge acquired during the fellowship to others in their home country upon their return. The candidate will have the choice to indicate his/her preference for the host site from a provided list of approved centers. It is imperative that the fellow be from a site that has the ability to perform complex spine surgery after completion of the fellowship. The SRS host may also visit the Winter fellow's home site to follow-up on skills and knowledge learned.

  • Four-to-six-week fellowship at a recognized global spine center which is staffed with SRS Active fellows.
  • Financial assistance approximating $12,000 to fund travel and lodging expenses.
  • Final report of the learning experience to be sent to the Scholarship and Awards Committee within two months of finishing the visiting fellowship.

Deadline: Application will open January 1 and close March 1, 2022.

Further information

 

Global haemophilia ASPIRE research awards, Pfizer, US

Pfizer invites proposals for its ASPIRE haemophilia research awards. These support research in gene therapy for haemophilia. Projects may fall under the following categories:

•basic and clinical science of gene therapy for haemophilia;

•basic and clinical science of TFPI and anti-TFPI monoclonal antibodies;

•burden of disease – clinical haemophilia A and B.

One grant is available for a basic science project, worth up to USD 90,000 per year for one to two years. One grant is available for a clinical science project, worth up to USD 110,000 per year for one to two years. Overhead rates of up to 28% of the total proposed project budget may be supported by Pfizer.

Deadline:  Proposal Deadline:1 March 2022; Anticipated Full Proposal Notification Date: May 2022.

Further information

Subscribe to Forskarstöd